Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study
SCOUT
Accuracy and Inter-observer Variability of Lung Ultrasound in COVID-19 Pneumonia
1 other identifier
interventional
50
1 country
1
Brief Summary
COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be normal, and early low-dose CT-scan is advocated to diagnose viral pneumonia. Lung ultrasound (LUS) has similar diagnostic properties as CT for diagnosing pneumonia. However, it has the advantage that it can be performed at point-of-care, minimizing the need to transfer the patient, reducing the number of health care personnel and equipment that come in contact with the patient and thus potentially decrease the risk of spreading the infection. This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2020
CompletedFirst Posted
Study publicly available on registry
April 8, 2020
CompletedStudy Start
First participant enrolled
April 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedAugust 17, 2020
August 1, 2020
8 months
April 4, 2020
August 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Accuracy of the diagnosis of interstitial syndrome by lung ultrasound
The diagnostic accuracy of lung ultrasound is more than 90% compared to low-dose CT or chest X-ray for the detection of viral pneumonia in patients with COVID-19 infection.
within 2 weeks after first subject included
Inter-observer variability
The interobserver variability by lung ultrasound between the 2 observers for the diagnosis of interstitial syndrome by lung ultrasound is \> 0.6 measured by the Kappa score
within 2 weeks after first subject included
Study Arms (2)
LUS observer 1
ACTIVE COMPARATORThe subject will undergo a Lung Ultrasound by observer nr 1
LUS observer 2
ACTIVE COMPARATORThe subject will undergo a Lung Ultrasound by observer nr 2
Interventions
The lung ultrasound examination consists of two-sided scanning of the anterior and lateral chest wall and is performed with patients in supine or near-to-supine position.
Eligibility Criteria
You may qualify if:
- years or older
- Oxygen saturation of \< 93% in ambient air
- Signed written informed consent
You may not qualify if:
- Contra-indication for lung ultrasound
- Other causes of hypoxia or of pulmonary infiltrates on CT thorax or chest X-ray
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- Ziekenhuis Oost-Limburgcollaborator
Study Sites (1)
Ziekenhuis Oost Limburg
Genk, Limburg, 3600, Belgium
Related Publications (3)
Ramirez P, Torres A. Should ultrasound be included in the initial assessment of respiratory patients? Lancet Respir Med. 2014 Aug;2(8):599-600. doi: 10.1016/S2213-2600(14)70142-0. Epub 2014 Jul 3. No abstract available.
PMID: 24998675BACKGROUNDPisani L, Vercesi V, van Tongeren PSI, Lagrand WK, Leopold SJ, Huson MAM, Henwood PC, Walden A, Smit MR, Riviello ED, Pelosi P, Dondorp AM, Schultz MJ; Lung Ultrasound Consortium. The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients. Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):44. doi: 10.1186/s40635-019-0241-6.
PMID: 31346914RESULTLi K, Fang Y, Li W, Pan C, Qin P, Zhong Y, Liu X, Huang M, Liao Y, Li S. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020 Aug;30(8):4407-4416. doi: 10.1007/s00330-020-06817-6. Epub 2020 Mar 25.
PMID: 32215691RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Michiel Thomeer, MD,PhD
Ziekenhuis Oost-Limburg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr.Michiel Thomeer
Study Record Dates
First Submitted
April 4, 2020
First Posted
April 8, 2020
Study Start
April 16, 2020
Primary Completion
November 30, 2020
Study Completion
December 30, 2020
Last Updated
August 17, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share
no plan